HOW TO EVALUATE NEW MEDICAL DISCOVERIES
By Harry K. Ziel, M.D.
Of late, the internet represents a great potential for transmission of
medical
misinformation to an unwary public. As the use of the internet geometrically
increases,
web surfers intent on learning the most up to date information on disease
treatment are
exposed to a vast array of unproved therapies. All the traditional
safeguards are lost when
usually well intentioned authors, enthusiastic to announce their discoveries,
pass along
their latest findings over the convenient computer network.
CAM "SCIENTIFIC' REPORTING
A patient with an unusual medical condition like pulmonary interstitial
fibrosis or
dermatomyositis may surf the web to find any number of sites which discuss his
condition. That unsophisticated patient may download, read, and believe that
medical
researchers have found that a particular diet or herbal medicine is effective
in treating his
disorder. Desperate with an uncommon disease that is showing no or slow
response to
traditional allopathic medicine (TAM), the patient is prone to look for and
to utilize a
number of complementary alternative medical (CAM) nostrums of no value or
even a
substance that causes harm. These computer web sites are the equivalent of
Tijuana
locations touting falsely advertised miracle cures that are falsely
advertised, like laetrile.
TAM SCIENTIFIC REPORTING
Excluding internet reporting, transmission of responsible scientific
information today
falls into the venue of a huge number of scientific journals. A hierarchy of
scientific
journals exists in each specialty area. Specialty organizations support the
publication of
most journals in their fields. For instance, the American Chemical Society's
publication
division supports publication of 27 different journals. In all,
publication companies in
United States print approximately 16,000 various peer-reviewed journals.
In each specialty area of medicine, a hierarchy of journals has
developed over time.
The most prestigious and selective medical journal is The New England
Journal of
Medicine (NEJM), published since 1812 by the Massachusetts Medical Society.
Only
one out of 10 articles submitted survives the NEJM peer review process. NEJM
editors
send articles submitted to anonymous reviewers, experts in the fields covered
by the
articles to be considered for publication. These highly responsible referees
must reject,
accept with recommended revision, or rarely accept without revision all
articles that clear
the editors' primary review.
A close second to the NEJM is the Journal of the American Medical
Association
(JAMA). The American Medical Association has published the JAMA since 1883.
The
JAMA also accepts about one in 10 articles submitted. For the fields of
general
medicine, these two journals have attained the first tier status in the
hierarchy of medical
journal reporting.
Journal editors today virtually require that all the authors have
subjected their data to
sophisticated statistical evaluation. One of the referees evaluating the
article is a
statistician who must peruse and agree with the testing of the data. First
tiered medical
journals require that authors follow set formats. Editors insist on
pertinent references
supporting views the authors present. Authors must disclose their sources of
financial
support. Purposals to perform research must first clear investigational
review boards
(IRBs). Before the research protocol starts, IRBs insist on meaningful
studies, check on
adequate size of patient cohorts to attain statistically significant
conclusions, require
patient consents which enumerate all patient risks as well as provision for
study
termination should patient injury become manifest.
Lower tiered journals tend to accept articles which meet with ever lower
standards of
quality review. The lowest tiered journals may accept and publish nearly all
articles
submitted. Obviously, one needs to scrutinize and be more wary of
conclusions tabulated
in the lower tiered journals. Unpublished internet findings have the least
degree of peer
review and accordingly should bear the greatest skepticism. Without any
ability to
review the material and methods, the statistical evaluation of the data, the
quality of
internet study conclusions are highly problematic.
HIGH FIBER DIET AND COLON CANCER
High quality peer reviewed reports can not be accepted fully, even if
data appear to be
statistically valid. Unrecognized biases often contaminate data. Statistical
validation
simply suggests truth. Only multiple studies, all statistically valid, each
concluding
similar findings, biologically plausible, with increasing exposure
correlating with
increasing effect will point to a causal rather than a casual association
between cause and
effect. The best studies are prospective in which patients are randomly
assigned to a
study group or a control group. Both the researchers and the patients are
unaware
(blinded) into which study or control group patients are enlisted. Study
medications and
placebos look alike. Researchers check compliance in taking medication by
inspecting
patient logs and remaining medication during each visit. Prospective
studies are long
and expensive.
As an alternative to prospective studies, researchers often choose to
perform
retrospective case control studies which are far faster and less expensive to
conduct than
prospective studies. Selection of control patients randomly chosen and
matched by age,
ethnicity, parity, Ponderal index, socioeconomic status etc. are paramount
to avoid bias
in retrospective case control studies. Simple observational studies,
sometimes matched
with historical controls, provide information of a far lessor quality on
which physicians
must sometime decide therapy when no better information is available.
To illustrate why multiple studies, each coming to the similar
conclusions, must be the
gold standard for scientific decision making, one needs only to point to the
recent NEJM
article which refutes the long held belief that a high fiber diet was
protective against
colon cancer. In 1971, Denis Burkitt first reported that Africans who ate a
high fiber diet
had a low incidence of colon cancer. A 1992 meta-analysis done by Howe et
al of 13
case control studies documented both a protective effect of fiber against
colon cancer as
well as a dose-response relationship (greater fiber use resulted in less
colon cancer
incidence). Thun et al in 1992 and Steinmetz et al in 1994 both showed an
inverse
relationship between high fiber intake and colon cancer occurrence indicating
protection
from colon cancer from fiber intake. Because of other associated benefits of
high fiber
intake, i.e., reduced incidence of diverticulosis, less coronary artery
atherosclerosis, lower
incidence of hypertension, and less frequent type 2 - non insulin dependent
diabetes, high
fiber became a highly encouraged prophylactic disease intervention. The fiber
bandwagon was rolling along!
Hints that fiber was ineffective in colon cancer prevention however
arose from four
publications. Responsible were DeCosse et al in 1989, McKeown-Eyssen et al
in 1994,
MacLennan et al in 1995, and Platz et al in 1997.
Fuchs et al in the January 21, 1999 issue of the NEJM reported from the
Nurses'
Health Study begun in 1976 that no protective association existed secondary
to the use of
high fiber diets from colon cancer or from premalignant adenomas known to
precede
colon cancer development. Their meticulous study refuted a belief held for
the past 28
years. The Nurses' Health Study is an ongoing prospective study of 88,757
women
conducted by a highly regarded research team at Harvard, one member of which
team,
Walter Willett, has made dietary influence on disease development his life's
work.
Shari Roan, writing in the January 25, 1999 Los Angeles Times, was quick
to jump
both on and off the Nurse's Health Band Wagon saying that the report shows
that one can
not trust a "lone study". Her assessment of where we stand in understanding
the causes
and prevention of colon adenomas and cancer is just what the public needs to
hear.
A true skeptic must say, "I still see no gold standard met. The story
of colon cancer
prevention is complicated by too many other factors than fiber ingestion. The
skeptic
requires many more studies involving complex carbohydrates and sugars,
carcinogens
derived from high temperature cooking , ingestion of smoked fish and meats,
camplobacter and other enteric pathogens, genetic predilection, as well as
pesticides and
other contaminants from foodstuffs and water to begin to find the solution to
the colon
cancer causes and prevention's. It's not a crime to admit one does not know.
SKEPTICISM MUST REIGN SUPREME !!!
The skeptic who steps outside the parade to await the final float before
he steps back
into line will experience the fewest upsets. The cocky drum major who heads
a parade is
most conspicuous if he leads followers who are all out of step. Scientific
proof may take
generations before discovery.
References:
1.Burkitt D P. Epidemiology of cancer of the colon and rectum. Cancer 1971;
28:3-13.
2. DeCosse J J, Miller H H, Lesser M L. Effect of wheat fiber and vitamins C
and E on
rectal polyps in patients with familial adenomatous polyposis. J Natl Cancer
Inst 1989;
81, 1290-1297.
3. Fuchs C S, Gioannucci E L, Colditz B A, Hunter J H, Stampfer M J, Rosner
B, Speizer
F E, Willett W C. Dietary Fiber and the Risk of Colorectal Cancer and
Adenoma in
Women. N Engl. J Med 1999; 340: 169-176.
4. Howe G R, Benito E, Castelleto R, et al. Dietary intake of fiber and
decreased risk of
cancers of the colon and rectum: evidence from the combined analysis if 13
case-control
studies, J Natl Cancer Inst 1992;84:1887-1896.
5. MacLennan R, Macrae F, Bain C, et al. Randomized trial of intake of fat,
fiber, and
beta carotene to prevent colorectal adenomas: the Australian Polyp Prevention
Project. J
Natl Cancer Inst 1995, 87:1760-1766.
6. McKeown-Eyssen G E, Bright-See E, Bruce W R, Jazmaji V. A randomized
trial of a
low fat high fibre diet in the recurrence of colorectal polyps: Toronto Polyp
Prevention
Group. J Clin Epidemol. 1994; 47:525-536.
7. Platz E A, Giovannucci E, Rimm E B, et al. Dietary fiber and distal
colorectal
adenoma in men. Cancer Epidemiol Biomarkers Prev 1997; 6: 661-670.
8. Steinmetz K A, Kushi L H, Bostick R M, Folsom A R, Potter J D.
Vegetables, fruit,
and colon cancer in the Iowa Woman's Health Study. Am J Epidemiol 1994; 139:
1-15.
9. Thun M J, Calle E E, Namboodiri M M, et al. Risk factors for fatal colon
cancer in a
large prospective study. J Natl Cancer Inst !992; 84: 1491-1500